Showing 4 of 4 recruiting trials for “primary-lipodystrophy”
Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
RecruitingNCT05996536 ↗
Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)
👨⚕️ Rebecca J Brown, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)📍 1 site📅 Started Jan 2024View details ↗
Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
👨⚕️ Rebecca J Brown, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)📍 1 site📅 Started Jan 2023View details ↗
Low Energy Diet and Familial Partial Lipodystrophy
👨⚕️ David Savage, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge📍 1 site📅 Started Jan 2020View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →